Snap-on Form 4: CEO Option Exercise and 10b5-1 Sales Reduce Holdings
Rhea-AI Filing Summary
Nicholas T. Pinchuk, Chairman, President and CEO of Snap-on Incorporated (SNA), reported option exercise and multiple open-market sales on 08/11/2025. He exercised stock options with an $138.03 exercise price to effect an acquisition of 33,750 shares, and pursuant to a Rule 10b5-1 plan (adopted October 24, 2024) sold a total of 23,042 shares in four transactions. The sales were executed at weighted-average prices of $320.1701, $320.969, $321.8626 and $322.618. Following these transactions, the filing shows Mr. Pinchuk directly beneficially owns 815,219.2893 shares, with an additional 858.5538 shares indirectly via a 401(k) plan and various outstanding options, restricted stock units, performance units and deferred stock units documented in the filing.
Positive
- None.
Negative
- None.
Insights
TL;DR Routine option exercise with planned sales under a 10b5-1 plan; sizable proceeds but beneficial ownership remains substantial.
The filing documents an exercise of 33,750 options at $138.03 and coordinated sales of 23,042 shares via a pre-established Rule 10b5-1 plan. Sales occurred at weighted-average prices between $320.17 and $322.62, implying multi-million dollar gross proceeds. This is a typical liquidity event for executives exercising vested options; it does not indicate an unusual one-off disclosure such as accelerated insider divestiture. The reporting also shows continued large holdings and multiple long-dated option grants and equity awards, which retain management alignment with shareholders.
TL;DR Transactions executed under a documented 10b5-1 plan and include option exercise plus pre-planned sales; disclosure follows expected SEC Form 4 practices.
The Form 4 states the transactions were carried out pursuant to a Rule 10b5-1 trading plan adopted on October 24, 2024, and notes the option exercised was fully vested. The filing provides weighted-average sale prices and commits to furnish trade-level details on request. From a governance perspective, use of a 10b5-1 plan and clear explanatory footnotes are appropriate controls for insider trading compliance and reduce ambiguity about intent behind sales.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Stock Option (Right to Buy) | 33,750 | $0.00 | $0.00 |
| Exercise | Common Stock | 33,750 | $138.03 | $4.66M |
| Sale | Common Stock | 5,209 | $320.1701 | $1.67M |
| Sale | Common Stock | 15,585 | $320.969 | $5.00M |
| Sale | Common Stock | 2,025 | $321.8626 | $652K |
| Sale | Common Stock | 223 | $322.618 | $72K |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Stock Option (Right to Buy) | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Restricted Stock Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Performance Units | -- | -- | -- |
| holding | Deferred Stock Units | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (16)
- F1. The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.
- F2. Includes 1.5215 shares acquired under a dividend reinvestment plan.
- F3. This transaction was executed in multiple trades at prices ranging from $319.49 to $320.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F4. This transaction was executed in multiple trades at prices ranging from $320.49 to $321.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F5. This transaction was executed in multiple trades at prices ranging from $321.49 to $322.48. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F6. This transaction was executed in multiple trades at prices ranging from $322.50 to $322.75. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.
- F7. This information is based on a plan statement dated June 30, 2025.
- F8. Option fully vested.
- F9. Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.
- F10. Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.
- F11. 1 for 1.
- F12. The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.
- F13. If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F14. If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F15. If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.
- F16. Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.
AI-generated analysis. How Rhea-AI works. Not financial advice.
